theranostics
GE HealthCare Joins EU Theranostics Consortium to Advance Radiopharmaceutical Development, Access
The new consortium, dubbed Thera4Care, launched with €25.3 million in EU government funding and 29 academic and industry partners.
Telix Seeks Approval of PET Imaging Agent Pixclara to Track Brain Cancer Treatment
Pixclara has potential as a companion diagnostic for Telix's LAT1-targeted radiopharmaceutical agent TLX101 in glioblastoma.
FDA Allowing Compassionate Use Access to Telix's Glioma PET Imaging Agent
Telix will seek FDA approval to sell TLX101-CDx as an imaging agent for advanced glioma patients.
Telix Files for FDA Approval for New PSMA-PET Imaging Agent TLX007-CDx
The firm already markets a radiopharmaceutical companion diagnostic for Pluvicto but is hoping to improve patient access with this new imaging agent.
Nuclidium, Guerbet Ink Deal to Develop Targeted Copper-Based Radiopharmaceuticals
The Swiss and French firms are teaming up to advance Nuclidium's pipeline of targeted radiopharmaceuticals using copper isotopes.